Pro-Dex Q2 net sales up 33% to $16.8M; EPS $0.61 vs $0.14

PRO DEX INC

2025-Q2 EPS reported $1.33 vs consensus $0.48 ▲ beat (+177.4%)

Q2 net sales $16.8M (+33% YoY) driven by $3.1M shipment of next-gen orthopedic handpiece for largest customer.
Net income $2.0M ($0.61 diluted) vs $0.5M ($0.14) prior year; gross margin 30% vs 22%.
Six-month net income $4.5M ($1.33 diluted) vs net loss $115K; includes $510K unrealized gains on investments.
Operating income rose 247% to $2.7M on higher sales and improved margins.
CEO expects Q3 and Q4 revenue growth from continued production shipments of next-generation handpiece.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.